5-hydroxymethylcytosine has been researched along with Melanoma in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (86.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gruis, N; Janssen, B; Kumar, R; Oosting, J; Salgado, C; van Doorn, R | 1 |
| Balzer, BL; Frishberg, DP; Shon, W; Yagi, S | 1 |
| Balzer, BL; Essner, R; Frishberg, DP; Huynh, CAT; Shon, W; Siref, AB | 1 |
| Gambichler, T; Sand, M; Skrygan, M | 1 |
| Ashida, A; Hayashi, K; Kiniwa, Y; Koga, H; Ogawa, E; Okuyama, R; Takazawa, Y; Uchiyama, A; Uchiyama, R; Uhara, H | 1 |
| Dresser, KA; Larson, AR; Lezcano, C; Lian, CG; Mihm, MC; Murphy, GF; Scolyer, RA; Shi, YG; Thompson, JF; Woda, BA; Yosufi, B; Zhan, Q | 1 |
| Granter, SR; Guo, W; Laga, AC; Lee, JJ; Lian, CG; Murphy, GF; Saavedra, AP; Xu, S; Zhan, Q | 1 |
| Burns, KH; Rodić, N; Sharma, R; Taube, JM; Zampella, J | 1 |
| Cook, M; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Wang, TJ; Xu, S; Zhan, Q | 1 |
| Fraitag, S; Hohl, D; Pavlova, O | 1 |
| Bamford, M; Joshi, K; Lawes, K; Moosa, F; Pringle, JH; Saldanha, G; Teo, KW | 1 |
| Chen, L; Gong, F; Guo, Y; Jin, J; Li, R; Ma, RZ; Niu, Y; Shi, X; Zhang, L; Zhang, X | 1 |
| Bresler, SC; Fletcher, CD; Frank, AH; Granter, SR; Hu, NR; Lee, JJ; Lian, CG; Mihm, MC; Murphy, GF; Saw, RP; Scolyer, RA; Vilain, RE; Xu, S | 1 |
| Hu, G; Jiang, MJ; Li, FJ; Li, LM; Long, J; Xu, C; Zhang, RH; Zhou, P | 1 |
| Ceol, C; Dresser, K; Duncan, LM; Fang, R; Houvras, Y; Hu, D; Hu, Y; Kaiser, UB; Kakavand, H; Khorasani, AJ; Kleffel, S; Larson, A; Lee, CW; Lezcano, C; Lian, BQ; Lian, CG; Mihm, MC; Murphy, GF; Neiswender, J; Schatton, T; Scolyer, RA; Shi, YG; Tan, L; Thompson, JF; Woda, BA; Wu, F; Xu, W; Xu, Y; Yang, Y; Zhan, Q; Zon, LI | 1 |
1 review(s) available for 5-hydroxymethylcytosine and Melanoma
| Article | Year |
|---|---|
The role of 5-hydroxymethylcytosine in melanoma.
Topics: 5-Methylcytosine; DNA Methylation; Epigenesis, Genetic; Humans; Melanoma | 2017 |
14 other study(ies) available for 5-hydroxymethylcytosine and Melanoma
| Article | Year |
|---|---|
Genome-wide characterization of 5-hydoxymethylcytosine in melanoma reveals major differences with nevus.
Topics: 5-Methylcytosine; 5' Untranslated Regions; Adult; Biomarkers, Tumor; CpG Islands; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus | 2020 |
Epigenetic marker expression is of limited diagnostic utility in spitzoid melanocytic neoplasms.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Epigenesis, Genetic; Female; Humans; Male; Melanoma; Nevus, Epithelioid and Spindle Cell; Skin Neoplasms | 2020 |
Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Diagnosis, Differential; Humans; Immunohistochemistry; Lymphatic Metastasis; MART-1 Antigen; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Skin Neoplasms; Staining and Labeling | 2019 |
Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma.
Topics: 5-Methylcytosine; Biomarkers, Tumor; Cytosine; Dioxygenases; Disease Progression; DNA-Binding Proteins; Epigenomics; Humans; Melanoma; Paraffin Embedding; Proto-Oncogene Proteins; Skin Neoplasms; Translocation, Genetic | 2013 |
5-Hydroxymethylcytosine as a useful marker to differentiate between malignant melanomas and benign melanocytic nevi.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers; CpG Islands; Cytosine; DNA Methylation; Epigenesis, Genetic; Female; Humans; Keratinocytes; Male; Melanoma; Middle Aged; Nevus, Epithelioid and Spindle Cell; Nevus, Pigmented; Skin Neoplasms | 2014 |
Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Cytosine; DNA Methylation; Female; Humans; Male; Melanoma; Middle Aged; Nevus; Precancerous Conditions; Skin Neoplasms; Young Adult | 2014 |
5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cytosine; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nevus; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2015 |
Diagnostic utility of 5-hydroxymethylcytosine immunohistochemistry in melanocytic proliferations.
Topics: 5-Methylcytosine; Cytosine; Diagnosis, Differential; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Melanocytes; Melanoma; Nevus, Pigmented; Skin Neoplasms; Tissue Array Analysis | 2015 |
Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma.
Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Small Cell; Cytosine; Epigenomics; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Male; Melanoma; Melanoma, Cutaneous Malignant; Middle Aged; Neoplasm Staging; Nevus, Pigmented; Prognosis; Skin Neoplasms; Young Adult | 2015 |
5-Hydroxymethylcytosine Expression in Proliferative Nodules Arising within Congenital Nevi Allows Differentiation from Malignant Melanoma.
Topics: 5-Methylcytosine; Adult; Analysis of Variance; Biopsy, Needle; Cohort Studies; Diagnosis, Differential; Disease Progression; Dysplastic Nevus Syndrome; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Melanoma; Melanoma, Cutaneous Malignant; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Retrospective Studies; Skin Neoplasms | 2016 |
5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Topics: 5-Methylcytosine; Age Factors; Aged; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Staging; Prognosis; Retrospective Studies; Skin; Skin Neoplasms; Survival Rate | 2017 |
Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; Decitabine; Dioxygenases; Disease Progression; DNA (Cytosine-5-)-Methyltransferases; DNA Demethylation; DNA Methylation; DNA Methyltransferase 3A; DNA-Binding Proteins; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Promoter Regions, Genetic; Proto-Oncogene Proteins; RNA, Small Interfering; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2017 |
5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms.
Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cohort Studies; Female; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Male; Melanoma; Middle Aged; Nevus, Pigmented; Retrospective Studies; Skin Neoplasms; Young Adult | 2017 |
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.
Topics: 5-Methylcytosine; Cytosine; Dioxygenases; DNA-Binding Proteins; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genome-Wide Association Study; Humans; Isocitrate Dehydrogenase; Melanocytes; Melanoma; Nevus; Proto-Oncogene Proteins | 2012 |